Evelyn Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Evelyn Partners's ABBV Position: Q3 2026 in Review
Evelyn Partners reduced its AbbVie (ABBV) stake by 1.5% in Q3 2026, selling an estimated $38.5K and leaving 9,651 shares worth $2.52M. The position accounts for 0.04% of the portfolio, ranked #148.
Evelyn Partners first reported a position in ABBV in Q2 2026 and has held it in 2 quarters since. 4,228 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Evelyn Partners held 9,651 shares of AbbVie worth $2.52M as of Q3 2026.
- Evelyn Partners sold 150 AbbVie shares in Q3 2026, an estimated $38.5K.
- AbbVie made up 0.04% of Evelyn Partners's portfolio in Q3 2026, its #148 holding.
- Evelyn Partners first reported a position in AbbVie in Q2 2026 and has held it in 2 quarters since.
- 4,228 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Evelyn Partners's 13F filing for Q3 2026, filed 10 Nov 2026.